Looking for Sentiment Analysis? Discover the most popular stocks on Reddit by using our Sentiment Tracker
Market Cap 35.58M P/E - EPS this Y 32.30% Ern Qtrly Grth -
Income -38.72M Forward P/E -1.40 EPS next Y 43.20% 50D Avg Chg 1.00%
Sales - PEG -0.01 EPS past 5Y - 200D Avg Chg 10.00%
Dividend N/A Price/Book 1.49 EPS next 5Y 40.90% 52W High Chg -73.00%
Recommedations 1.50 Quick Ratio 2.84 Shares Outstanding 5.48M 52W Low Chg 327.00%
Insider Own 5.14% ROA -40.25% Shares Float 2.79M Beta -2.12
Inst Own 47.75% ROE -248.11% Shares Shorted/Prior 21.64K/31.11K Price 15.15
Gross Margin - Profit Margin - Avg. Volume 81,293 Target Price 15.00
Oper. Margin - Earnings Date Nov 11 Volume 123,403 Change 2.57%
About Kala Pharmaceuticals, Inc.

KALA BIO, Inc., a clinical-stage biopharmaceutical company, engages in the research, development, and commercialization of innovative therapies for rare and severe eye diseases in the United States. The company's product candidates include KPI-012, which is in Phase 2b clinical trial for the treatment of persistent corneal epithelial defects. Its preclinical development product, including KPI-014 for the treatment of rare inherited retinal diseases. The company was formerly known as Kala Pharmaceuticals, Inc. and changed its name to KALA BIO, Inc. in August 2023. KALA BIO, Inc. was incorporated in 2009 and is headquartered in Arlington, Massachusetts.

KALA Chatroom

User Image MRCOCO69 Posted - 2 days ago

$KALA CEO and all management should be jailed. What they are doing with this company is criminal. No revenue, no pipeline, just constant offerings to pay their salaries and scam investors. CRIMINAL

User Image HFH_Inc Posted - 3 days ago

$PULM How about if we do a $KALA here? Winning like Trump in here in a landslide.

User Image HFH_Inc Posted - 5 days ago

$PULM Could this be another $KALA from early 2023? Guess who is CEO of Kala and former long time board member here? Guess who is current COO of Kala and current board member here? Answer: Marc Iwicki & Todd Bazemore. Anyway, that stock peaked on the mid-$50's in that run.

User Image Investor203 Posted - 1 week ago

$QUBT early days of $HKD and $KALA . Hold on for the power hour

User Image Investor203 Posted - 1 week ago

$QUBT reminds me $HKD and $KALA . Get in early for higher rewards

User Image HFH_Inc Posted - 1 week ago

$PULM Remember $KALA ?

User Image Stocksrunner Posted - 1 week ago

Weekend Watchlist: While the market rests, $VMAR $KALA $DTST $MNMD and $NOTV made big moves before the close. Analyze the action and prep for Monday!

User Image RealErnFranklin Posted - 10/27/24

$KALA going to touch the moon $BAER over $3 bullish $AMST my favorite ticker, only slow pops * $ATPC nice momentum trade ready for right now !

User Image Charleslapi99 Posted - 10/25/24

$KALA About to send HARD!!!

User Image FetchDog Posted - 10/25/24

$KALA My buy order at $4.92 on October 17 did not get filled by $0.03. That's what I get for being a cheapskate. Happening too often lately, small bios are taking off.

User Image Precious96 Posted - 10/24/24

$KALA Get ready!!!

User Image EDayTrade Posted - 10/24/24

$KALA We are at four times the average daily volume right now and it’s only 1 o’clock. Somebody knows something.

User Image Charleslapi99 Posted - 10/23/24

$KALA bullish KALA

User Image Charleslapi99 Posted - 1 month ago

@Stmkr Going to be something here 😎 $XBI $ALGS $KALA

User Image Stmkr Posted - 1 month ago

$KALA "Topline data from Phase 2b CHASE trial of KPI-012 for PCED targeted in Q1 2025" Time to reverse course?

User Image PenkeTrading Posted - 09/27/24

I found you an Oversold RSI (Relative Strength Index) on the daily chart of Kala Pharmaceuticals Inc. Is that bullish or bearish? $KALA #Kala #RsiOversold #NASDAQ

User Image 2Haflingers Posted - 2 months ago

$KALA Dead money . Im out

User Image Investor203 Posted - 2 months ago

$OMEX $gme $KALA $AMC let’s go

User Image redfox43202 Posted - 2 months ago

$KALA How is drug development going? Is it going to be a repeat of the dry eye drug success?

User Image MRCOCO69 Posted - 2 months ago

$KALA what a great company. Just zoom out since inception. This is Nvidia inverted...

User Image great_investment_thesis Posted - 08/30/24

$KALA The preliminary data must be compelling enough to support a BLA submission after Phase 2b. Regardless, they may still need to raise capital in mid to late 2025 to commercialize the product. It's not a bad long-term bet, as annual revenues could reach several hundred million dollars.

User Image Precious96 Posted - 08/27/24

$KALA https://journey.ct.events/view/58697872-ab4d-44b5-ac19-835e75e99538 We should know more news on success of the trials by Q1 2025

User Image Investor203 Posted - 08/23/24

$LUMO can be next $KALA $PSIG or $HKD . Buckle up!

User Image MRCOCO69 Posted - 08/22/24

$KALA straight to zero again. Reverse split and repeat...

User Image Thestocktraderhubzee Posted - 3 months ago

$KALA Oppenheimer Reiterates Outperform on Kala Bio, Maintains $15 Price Target

User Image 2Haflingers Posted - 3 months ago

$KALA Zacks just upgraded. Good news imminent.

User Image MRCOCO69 Posted - 3 months ago

$KALA Shorting this POS since 2017

User Image 2Haflingers Posted - 3 months ago

$KALA No reason for this drop.. good er.

User Image EDayTrade Posted - 3 months ago

$KALA So is this good, bad, or just so-so.

User Image epsguid Posted - 3 months ago

$KALA reported a loss of $3.16, consensus was ($4.41) via @eWhispers #epsbeat http://eps.sh/d/kala

Analyst Ratings
Oppenheimer Outperform Aug 19, 24
HC Wainwright & Co. Buy May 17, 24
HC Wainwright & Co. Buy Apr 2, 24
Oppenheimer Outperform Apr 1, 24
HC Wainwright & Co. Buy Nov 17, 23
HC Wainwright & Co. Buy Aug 11, 23
HC Wainwright & Co. Buy May 10, 23
HC Wainwright & Co. Buy May 1, 23
HC Wainwright & Co. Buy Apr 12, 23
Insider Trades Relationship Date Transactions Cost($) #Shares Value($) #Share Own SEC Form 4
Trachtenberg Eric SEE REMARKS SEE REMARKS Jan 04 Sell 28.55 60 1,713 11,495 01/06/23
Reumuth Mary CHIEF FINANCIAL OFFI.. CHIEF FINANCIAL OFFICER Jan 04 Sell 28.54 60 1,712 11,883 01/06/23
Brazzell Romulus K SEE REMARKS SEE REMARKS Jan 04 Sell 28.53 73 2,083 18,536 01/06/23
Bazemore Todd SEE REMARKS SEE REMARKS Jan 04 Sell 28.54 62 1,769 14,835 01/06/23
Iwicki Mark T CHIEF EXECUTIVE OFFI.. CHIEF EXECUTIVE OFFICER Jan 04 Sell 28.54 198 5,651 45,966 01/06/23
Trachtenberg Eric SEE REMARKS SEE REMARKS Jun 27 Sell 0.37 2,613 967 111,203 06/29/22
Reumuth Mary CHIEF FINANCIAL OFFI.. CHIEF FINANCIAL OFFICER Jun 27 Sell 0.37 2,613 967 130,595 06/29/22
Brazzell Romulus K SEE REMARKS SEE REMARKS Jun 27 Sell 0.37 3,144 1,163 285,201 06/29/22
Bazemore Todd SEE REMARKS SEE REMARKS Jun 27 Sell 0.37 3,092 1,144 115,499 06/29/22
Iwicki Mark T CHIEF EXECUTIVE OFFI.. CHIEF EXECUTIVE OFFICER Jun 27 Sell 0.37 7,975 2,951 251,183 06/29/22
RA CAPITAL MANAGEMENT, L.P. 10% Owner 10% Owner May 26 Sell 0.3636 1,005,686 365,667 7,039,613 05/26/22
RA CAPITAL MANAGEMENT, L.P. 10% Owner 10% Owner May 23 Sell 0.53 2,829,314 1,499,536 8,045,299 05/25/22
Chen Hongming CHIEF SCIENTIFIC OFF.. CHIEF SCIENTIFIC OFFICER Oct 26 Sell 1.81 30,500 55,205 204,515 10/28/21